HETEROCYCLES, Vol. 78, No. 2, 2009
461
solvent was evaporated under reduced pressure and the crude product 5 was purified by column
1
chromatography using CH2Cl2/acetone (30:1) as the eluent to give 725 mg (60%) of 5. mp 101 ˚C; H
NMR (CDCl3) δ: 2.15 (qui, 2H, J = 7.4 Hz), 2.85 (t, 2H, J = 7.5 Hz), 2.95 (t, 2H, J = 7.7 Hz), 3.42 -3.49
(m, 4H), 3.90 – 4.01 (m, 4H), 4.8 – 5.0(brs, 2H) 7.24 (d, 1H, J = 8.4 Hz), 7.59 (t, 1H, J = 7.8 Hz), 7.78 (s,
1H), 7.84 (d, 1H, J = 7.6 Hz); 13C NMR (CDCl3) δ: 24.1, 30.3, 32.7, 33.0, 33.2, 62.7, 63.3, 114.3, 117.4,
122.3, 137.0, 138.0, 153.4, 153.6, 154.5, 155.7, 158.0; IR (KBr) cm-1: 3355.2, 1554,6 1143.9; Anal. Calcd
for C17H20N2S2O2: C, 58.62; H, 5.75; N, 8.04. Found C, 58.58; H, 5.93; N, 8.03.
Synthesis
of
1-(2-(allyloxy)ethylthio)-3-(6-(2-(allyloxy)ethylthio)pyridin-2-yl)-6,7-dihydro-5H-
cyclopenta[c]pyridine (6).
To a mixture of 5 (1.16 g, 3.3 mmol) and NaH (0.46 g, 19.2 mmol) in dry DMF (50 mL), allyl bromide
(1.4 mL, 16.2 mmol) in DMF (10 mL) was added. The mixture was stirred at rt for 6 h. The reaction
mixture was poured into ice/H2O and acidified with AcOH. For 6 the water layer was extracted with Et2O.
The organic layers were dried over MgSO4 and evaporated in vacuo. The crude product 6 was purified by
column chromatography using CH2Cl2/acetone (100:1) as the eluent to provide 0.772 g (54%) of 6 as a
white oil; 1H NMR (CDCl3) δ: 2.15 (qui, 2H, J = 7.7 Hz), 2.84 (t, 2H, J = 7.4 Hz), 2.92 (t, 2H, J = 7.6 Hz),
3.48 – 3.59 (m, 4H), 3.75 – 3.82 (m, 4H), 4.04 – 4.08 (m, 4H), 5.14 – 5.34 (m, 4H), 5.87 – 6.00 (m, 2H),
7.16 (dd, 1H, J = 0.7 Hz, J = 7.8 Hz), 7.57 ( t, 1H, J = 7.8 Hz), 8.04 (s, 1H), 8.11 (dd, 1H, J = 0.8 Hz, J =
13
7.7 Hz); C NMR (CDCl3) δ: 24.2, 28.6, 29.1, 30.0, 33.0, 69.1, 69.2, 71.9, 113.1, 116.5, 117.0, 121.7,
134.5, 134.6, 136.6, 137.5, 152.4, 153.4, 153.9, 159.0,157.0; IR (KBr) cm-1: 1094, 1142; HRMS (m/z) for
C23H28N2S2O2: 428.1603 [M+]; Calcd. 428.1592.
Synthesis
of
3,4,6,9,11,12,22,23-octahydro-21H-18,14:19,1-diepiazenocyclopenta[f]-
[1,18,4,15]dioxadithiacyclodocosine (7)
A solution each of the substrate 6 (150 mg, 0.35 mmol) in CH2Cl2 (c = 0.01M) and Grubbs’ catalyst I (80
mg, 10 mol %) was heated under reflux for 6 h. The solvent was removed in vacuo and the crude product
was separated by column chromatography, using CH2Cl2/hexane (100:1) as the eluent. Analytically pure
compound 6 was recrystallized from EtOH as white solid to provide 98 mg (70%) of 7. mp 204 – 206 ºC;
1H NMR (CDCl3) δ: 2.10 (qui, 2H, J = 7.2 Hz), 2.84 (t, 2H, J = 7.6 Hz), 2.99 (t, 2H, J = 7.8 Hz), 3.34 –
3.43 (m, 4H), 3.55 – 3.66 (m, 4H), 3.88 – 4.10 (m, 4H), 5.63 – 5.86 (m, 2H), 7.04 (dd, 1H, J = 0.7 Hz, J =
7.4 Hz), 7.48 (t, 1H, J = 7.8 Hz), 7.95 (s, 1H), 8.01 (dd, 1H, J = 0.7 Hz, J = 7.2 Hz); 13C NMR (CDCl3) δ:
24.23, 26.8, 29.3, 33.0, 51.2, 59.2, 68.9, 70.0, 70.5, 70.6, 70.7, 113.1, 116.5, 121.6, 129.5, 138.4, 137.5,
153.9, 154.3, 155.8, 157.5; IR (KBr) cm-1: 1104, 1142; HRMS (m/z) for C21H24N2S2O2: 400.1273 [M+];
Calcd. 400.1226.